Search - tctmd.com

Displaying 21 - 30 of 30

Sort: Relevancy | Date

Presentation NY Valves 2024

SAVR is Clearly the Gold Standard in AS Patients Under 65 Years Old

Presenter: Keith B. Allen

June 06, 2024

Presentation NY Valves 2024

SAVR After TAVR: A Dangerous Epidemic?

Presenter: Shinichi Fukuhara

June 06, 2024

Presentation NY Valves 2024

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

Presenter: Tsuyoshi Kaneko

June 06, 2024

Presentation NY Valves 2024

SAVR for the Small Annulus Patient – Surgical Trends and Perspectives

Presenter: Hendrik Treede

June 06, 2024

Presentation NY Valves 2024

SAVR Will Have a Longer Lasting Durability Than TAVR

Presenter: Stephan Windecker

June 06, 2024

Presentation NY Valves 2024

Determinants of Intervention Type and All-Cause Mortality of TAVR and SAVR Patients Younger Than 75 Years in the Netherlands

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Presentation NY Valves 2024

TAVR Will Have a Longer Lasting Durability Than SAVR

Presenter: Michael J. Reardon

June 06, 2024

Presentation NY Valves 2024

Cases 3/4 : SAVR at 10 Years and SVD at 2 Years: Echo and Clinical

Presenter: Mark Lebehn

June 06, 2024

Presentation NY Valves 2024

Defining the Small Annulus Patient: TAVR and SAVR Perspectives

Presenter: Dee Dee Wang

June 06, 2024

Presentation NY Valves 2024

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

Presenter: Ole De Backer

June 05, 2024

Advertisement

SAVR is Clearly the Gold Standard in AS Patients Under 65 Years Old

SAVR After TAVR: A Dangerous Epidemic?

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

SAVR for the Small Annulus Patient – Surgical Trends and Perspectives

SAVR Will Have a Longer Lasting Durability Than TAVR

Determinants of Intervention Type and All-Cause Mortality of TAVR and SAVR Patients Younger Than 75 Years in the Netherlands

TAVR Will Have a Longer Lasting Durability Than SAVR

Cases 3/4 : SAVR at 10 Years and SVD at 2 Years: Echo and Clinical

Defining the Small Annulus Patient: TAVR and SAVR Perspectives

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content